Outset Medical (OM) Net Equity Issued and Repurchased (2020)
Outset Medical's (OM) quarterly Net Equity Issued and Repurchased came in at -$923000.0 in Q4 2020, down 100.72% quarter-over-quarter from $129.0 million in Q3 2020.
Powered by 
Analysis
Outset Medical (OM) Net Equity Issued and Repurchased (2020) Analysis & Trends
Outset Medical (OM) has reported Net Equity Issued and Repurchased for 1 consecutive years, with -$923000.0 the latest figure, recorded in Q4 2020.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$923000.0 in Q4 2020; TTM through Sep 2022 was -$923000.0, a 100.72% decrease from a year earlier, with the FY2021 full-year figure at $149.1 million, down 41.49% from the prior year.
- Net Equity Issued and Repurchased was -$923000.0 for Q4 2020 at Outset Medical, down from $129.0 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $129.0 million in Q3 2020 and troughed at -$923000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.06 Bn | 174.46 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.71 Bn | 122.50 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.33 Bn | 108.51 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 103.92 Bn | 100.45 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.13 Bn | 62.59 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.84 Bn | 45.59 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.98 Bn | 31.52 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | - |
| 10 | Outset Medical | 59.95 Mn | -203.24 Mn | 13.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -923,000.00 |
| Sep 30, 2020 | 128.97 Mn |
| Mar 31, 2020 | 126.76 Mn |